Cellectis S a (CLLS) - News Archive

In the financial landscape, transparency, and regulatory compliance are pivotal for maintaining investor trust and securing the integrity of the capital markets. In alignment with these priorities, companies listed on t...

In a significant move to bolster corporate transparency, the French financial markets authority has invoked 223-16 of its General Regulations, compelling companies to provide detailed monthly reports on their share capi...

In recent developments within the biotechnology sector, Cellectis S.A. has made significant strides in cancer therapy research, publishing a promising article on its SMART DUAL CAR T-cell approach for treating recalcitr...

Monthly information on share capital and company voting rights In accordance with 223-16 of the General Regulations of the French financial markets authority, Cellectis S.A. has released its monthly information on share...

In a significant move to address the growing demand for innovative therapeutics, Cellectis, a leading biotechnology company, has entered into a strategic collaboration and investment agreements with AstraZeneca. These a...